Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

18.2%

2 terminated/withdrawn out of 11 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

18%

2 trials in Phase 3/4

Results Transparency

38%

3 of 8 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A
3(42.9%)
Phase 2
2(28.6%)
Phase 3
1(14.3%)
Phase 4
1(14.3%)
7Total
N/A(3)
Phase 2(2)
Phase 3(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)